Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient

被引:8
作者
Munchel, Ashley [1 ,2 ]
Chen, Allen [3 ,4 ]
Symons, Heather [3 ,4 ]
机构
[1] Johns Hopkins Univ Hosp, Pediat Hematol Oncol, Baltimore, MD USA
[2] NIH, Pediat Oncol Branch, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Div Oncol, Baltimore, MD USA
[4] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Div Pediat, Baltimore, MD USA
关键词
hematopoietic cell transplantation; immunosuppression; congestive heart failure; diffuse alveolar hemorrhage; idiopathic pulmonary syndrome; bronchiolitis obliterans; posterior reversible encephalopathy; thrombotic microangiopathy; graft-versus-host disease; infection; hemorrhagic cystitis; calcineurin inhibitor;
D O I
10.1016/j.cpem.2011.07.005
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hematopoietic cell transplantation is the only potentially curative option for a variety of pediatric malignant and nonmalignant disorders. Despite advances in transplantation biology and immunology as well as in posttransplant management that have contributed to improved survival and decreased transplant-related mortality, hematopoietic cell transplantation does not come without significant risk of complications. When patients who have undergone hematopoietic cell transplantation present to the emergency department, it is important to consider a variety of therapy-related complications to optimize management and outcome. In this article, we use clinical cases to highlight some of the more common emergent complications after hematopoietic cell transplantation.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 107 条
  • [1] Arai S, 2001, Hematol J, V2, P292, DOI 10.1038/sj.thj.6200127
  • [2] Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer
    Ariffin, H
    Arasu, A
    Mahfuzah, M
    Ariffin, WA
    Chan, LL
    Lin, HP
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2001, 37 (01) : 38 - 43
  • [3] Cefepime monotherapy for treatment of febrile neutropenia in children
    Ariffin, Hany
    Ai, Chong Lee
    Lee, Chan Lee
    Abdullah, Wan Ariffin
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (12) : 781 - 784
  • [4] ATKINSON K, 1990, BLOOD, V75, P2459
  • [5] Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab
    Au, Wing-Yan
    Ma, Edmond S.
    Lee, Tsz-Leung
    Ha, Shau-Yin
    Fung, Alvin T.
    Lie, Albert K. W.
    Kwong, Yok-Lam
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 475 - 478
  • [6] Prophylaxis of acute GVHD: manipulate the graft or the environment?
    Barrett, A. John
    Le Blanc, Katarina
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 165 - 176
  • [7] Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
    Batts, E. D.
    Lazarus, H. M.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 40 (08) : 709 - 719
  • [8] Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children
    Ben-Abraham, R
    Paret, G
    Cohen, R
    Szold, O
    Cividalli, G
    Toren, A
    Nagler, A
    [J]. CHEST, 2003, 124 (02) : 660 - 664
  • [9] Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
    Benjamin, DK
    Driscoll, T
    Seibel, NL
    Gonzalez, CE
    Roden, MM
    Kilaru, R
    Clark, K
    Dowell, JA
    Schranz, J
    Walsh, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 632 - 638
  • [10] CYCLOPHOSPHAMIDE CARDIOTOXICITY IN BONE-MARROW TRANSPLANTATION - A PROSPECTIVE EVALUATION OF NEW DOSING REGIMENS
    BRAVERMAN, AC
    ANTIN, JH
    PLAPPERT, MT
    COOK, EF
    LEE, RT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1215 - 1223